Expert OpinionScreening for Occult Heart Failure (HF) in Type 2 Diabetes Mellitus (T2DM) using NT-proBNPDr Ameya Joshi
PublicationsChinese expert consensus on the risk assessment and management of panvascular disease in patients with type 2 diabetes mellitus (2022 edition)
STRONG-HFImplementation of STRONG-HF protocol in heart failure management: an Australian perspectiveProf Andrew JS Coats
STRONG-HFUnleashing the Power of STRONG-HF: Enabling Transformation in Heart Failure Management Across ChinaCardio ThinkLab
PublicationsScreening & Diagnosis of Heart Failure in Pre-Diabetic and Diabetic PatientsCardio ThinkLab
Expert OpinionQuantum leap in reducing rehospitalization in HF by 70-80% – How and where?Dr Aekarach Ariyachaipanich
STRONG-HFSTRONG-HF: Rapid Uptitration of Guideline Directed Medical Therapy for Heart FailureProf Alexandre Mebazaa
PublicationsGuidelines Interpretation – Guidelines for the management of chronic heart failure in dialysis patients in ChinaProf Jiang Hongli
STRONG-HFHeart failure management in Australia and the role of NT-proBNP in monitoring and treatmentProf John Amerena
STRONG-HFDownload APAC STRONG-HF Master Pack: First-hand Insights from Prof Mebazaa on Heart Failure Treatment MonitoringCardio ThinkLab
STRONG-HFSTRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure TherapyProf Alexandre Mebazaa
proCardio Asia PacificNT-proBNP and ECHO in heart failure – do they always go hand in hand?Prof Andrew Sindone
Expert OpinionClinical Application Value of NT-proBNP in Chronic Kidney Diseases Patients with Cardiovascular DiseasesDr Gan Liangying
Local StoriesManagement of Diabetes in Japan – Can Patients Play a More Significant Role?Dr Kumiko Hamano
Expert OpinionNT-proBNP: Increasing Clinical Confidence in Heart Failure ManagementProf Andrew Sindone
Expert OpinionHeart Failure Prevention in T2DM – Essence of JCS/JDS joint consensusDr Yasunori Takata